CKX.F CRYOPORT INC. DL-01
- Market cap
- EUR 937M
- P/E
- -
- P/B
- 2.42x
- ROE
- -8.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is CKX.F undervalued?
Graham numberThe Graham number of CRYOPORT INC. DL-01 cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CRYOPORT INC. DL-01 fundamental analysis
No fundamental analysis for CRYOPORT INC. DL-01 yet.
CRYOPORT INC. DL-01 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About CRYOPORT INC. DL-01
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life sc…
Full company profileCRYOPORT INC. DL-01 financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
CRYOPORT INC. DL-01 annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 223M | 237M | 169M | 157M | 176M | 196M |
| Gross Profit | 96.6M | 104M | 75.3M | 69.7M | 83.1M | 91.4M |
| Operating Income | -17.8M | -31.9M | -51.0M | -57.9M | -36.8M | -37.9M |
| EBITDA | - | -6.19M | -51.1M | -69.6M | -2.10M | -9.08M |
| Net Income | -276M | -37.3M | -99.6M | -115M | 78.3M | -39.5M |
| EPS | -5.55 | -0.77 | -2.03 | -2.30 | 1.57 | -0.78 |
| Balance Sheet | ||||||
| Total Assets | 1.11B | 1.04B | 958M | 703M | 765M | 751M |
| Total Liabilities | 471M | 483M | 469M | 302M | 262M | 267M |
| Shareholders' Equity | 642M | 556M | 489M | 402M | 503M | 484M |
| Cash & Short-term Investments | 139M | 36.6M | 46.3M | 45.3M | 250M | 279M |
| Cash Flow | ||||||
| Operating Cash Flow | 8.13M | -1.85M | -757K | -16.3M | -8.58M | 13.4M |
| Capital Expenditure | 25.0M | 24.2M | 44.9M | 21.3M | 19.5M | 34.6M |
| Free Cash Flow | -16.9M | -26.0M | -45.7M | -37.6M | -28.1M | -21.1M |
| Ratios | ||||||
| ROE | -42.9% | -6.7% | -20.4% | -28.6% | 15.6% | -8.2% |
| ROA | -24.8% | -3.6% | -10.4% | -16.3% | 10.2% | -5.3% |
| Net Profit Margin | -123.8% | -15.7% | -59.0% | -73.2% | 44.4% | -20.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
CRYOPORT INC. DL-01 dividends
CRYOPORT INC. DL-01 has not paid dividends in the last 5 fiscal years.
Who owns CRYOPORT INC. DL-01
- Insiders 3.85%
- Institutions 96.15%
- Public & others 0.00%
- Shares outstanding 50.6M
- Free float 46.0M
CRYOPORT INC. DL-01 company profile
- Company name
- CRYOPORT INC. DL-01
- Ticker
- CKX.F
- Exchange
- Frankfurt Exchange
- Sector
- Industrials
- Industry
- Air Freight & Logistics
- Employees
- 684
- Fiscal year end
- December
- Address
- 112 Westwood Place, Brentwood, TN, United States, 37027
- Phone
- 949 470 2300
- Website
- cryoportinc.com
About CRYOPORT INC. DL-01
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.
CRYOPORT INC. DL-01 management
9- Mr. Jerrell W. SheltonChairman, President & CEO · born 1945
- Mr. Robert S. Stefanovich MSSenior VP, CFO, Treasurer & Chief Administrative Officer · born 1965
- Mr. Edward J. ZecchiniSenior VP and Chief Digital & Technology Officer · born 1962
- Dr. Mark W. Sawicki Ph.D.Senior VP & Chief Scientific Officer
- Mr. Chris LaGulloChief Operating Officer
- Mr. Thomas J. HeinzenVice President of Corporate Development & Investor Relations
- Mr. Tony IppolitoVP, General Counsel & Corporate Secretary
- Ms. Kylie A. CroweVice President of Global Human Resources & Organizational Development
- Mr. Phil WilsonChief Operating Officer of Cryoport Systems, LLC